» Articles » PMID: 1978682

Rearrangements in the LDL Receptor Gene in Dutch Familial Hypercholesterolemic Patients and the Presence of a Common 4 Kb Deletion

Overview
Journal Atherosclerosis
Publisher Elsevier
Date 1990 Aug 1
PMID 1978682
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

DNA samples from 53 unrelated Dutch patients with familial hypercholesterolemia (FH) were screened for rearrangements in the gene for the LDL receptor (LDLR) by Southern analysis. Four different mutations have been detected by hybridisation of BglII digested genomic DNA with an exon 10-14 containing cDNA probe. The mutations are defined by a 7 kb insertion near exon 11, a partial gene duplication encompassing exons 9-12, a 4 kb deletion of exons 7 and 8 and an 0.4 kb deletion comprising the 5'-part of exon 16. These four different rearrangements in the LDLR gene account for 17% of the mutations in the Dutch FH population sample. Interestingly, the 4 kb deletion was detected in 5 unrelated FH patients (9.5%) and appeared to be identical to the deletion previously described (Russell, D.W. et al., Arteriosclerosis, 9 (Suppl. I) (1989) I-8; Russell, D.W. et al., Cold Spring Harbor Symp. Quant. Biol., 51 (1987) 401). in an FH patient of Dutch origin. This suggests that the 4 kb deletion is a common mutation in the Dutch FH population.

Citing Articles

Inhibition of amyloid-beta aggregation by phenyl butyric acid analogs and bile acids: a comprehensive in silico study.

Singh R, Kaur N, Sharma S, Dhingra N, Kaur T Mol Divers. 2025; .

PMID: 39873884 DOI: 10.1007/s11030-024-11101-6.


Exploring characteristic features for effective HCN1 channel inhibition using integrated analytical approaches: 3D QSAR, molecular docking, homology modelling, ADME and molecular dynamics.

Sharma S, Rana P, Chadha V, Dhingra N, Kaur T Eur Biophys J. 2024; 53(7-8):447-464.

PMID: 39488633 DOI: 10.1007/s00249-024-01726-8.


C-5401331 identified as a novel T-cell immunoglobulin and mucin domain-containing protein 3 (Tim-3) inhibitor to control acute myeloid leukemia (AML) cell proliferation.

Al Shahrani M, Gahtani R, Makkawi M Med Oncol. 2024; 41(3):63.

PMID: 38265498 DOI: 10.1007/s12032-023-02296-z.


PCSK9 inhibition fails to alter hepatic LDLR, circulating cholesterol, and atherosclerosis in the absence of ApoE.

Ason B, van der Hoorn J, Chan J, Lee E, Pieterman E, Nguyen K J Lipid Res. 2014; 55(11):2370-9.

PMID: 25258384 PMC: 4617138. DOI: 10.1194/jlr.M053207.


The role of calcium in lipoprotein release by the low-density lipoprotein receptor.

Zhao Z, Michaely P Biochemistry. 2009; 48(30):7313-24.

PMID: 19583244 PMC: 2749037. DOI: 10.1021/bi900214u.